Source: Annual Congress 2003 - Induction and modulation of lung cell damage
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Rydell, L. Uller, C. G. A. Persson, J. S. Erjefält (Lund, Sweden). Primary and secondary necrosis as local determinants of LPS-induced airway inflammation. Eur Respir J 2003; 22: Suppl. 45, 3679

Member's Comments

No comment yet.

Related content which might interest you: Impaired lung neutrophil clearance causes necrosis and enhanced inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 452s Year: 2004 Ketotifen induces primary necrosis in eosinophils Source: Eur Respir J 2004; 24: Suppl. 48, 36s Year: 2004 LSC Abstract – Role For IL-1alpha in viral-induced inflammatory responses in an epithelial-fibroblast co-culture model of the airway mucosa Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Inflammation and remodeling modulated by anti IL17 in model of lung injury induced by elastase in mice Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling Year: 2019 Does tumor necrosis factor-alpha increase oxidative stress in bronchial asthma? Source: Eur Respir J 2003; 22: Suppl. 45, 111s Year: 2003 Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Evaluation of lung parenchyma and peribronchial edema formation in a model of chronic airway inflammation in guinea pigs: Effects of acute and chronic nitric oxide inhibition Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003 Characterisation of endogenous IL-33 using a model of Alternaria-induced pulmonary inflammation Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 N-acetylcysteine reduces tumor necrosis factor-α release by alveolar macrophages of interstitial lung disease in vitro Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007 Cytokines and local inflammation in pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 376s Year: 2005 LPS induced airway inflammation in man Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Hepatocyte growth factor attenuates airway hyperresponsiveness and airway inflammation in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 27s Year: 2002 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Eur Respir Rev 2006; 15: 207-208 Year: 2006